Belmont, CA, United States of America

Christoher Don Roberts


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christopher Don Roberts - Innovator in Antibacterial and Antifungal Agents

Introduction

Christopher Don Roberts, an accomplished inventor based in Belmont, California, has made significant strides in the field of pharmaceuticals. With one patent to his name, he has contributed to the development of novel compounds that are essential for combating various infectious agents. His work at Genelabs Technologies, Inc. showcases his commitment to advancing medical science and improving public health.

Latest Patents

Roberts holds a patent for "Aryl and heteroaryl compounds as antibacterial and antifungal agents." This invention features innovative compounds that possess antibacterial, antifungal, and even antitumor activities. Moreover, the patent outlines pharmaceutical compositions containing these compounds, methods for their synthesis, and various applications for their use in therapeutic settings.

Career Highlights

Working at Genelabs Technologies, Inc., Roberts has focused his expertise on creating solutions that address pressing medical challenges. The impact of his patent is poised to enhance treatment options for patients suffering from infectious diseases. His dedication and ingenuity have established him as a valuable contributor to the field of biomedical research and pharmaceutical development.

Collaborations

In his professional journey, Roberts has collaborated with talented individuals like Jesse Daniel Keicher and Mikail Hakan Gezginci. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of knowledge, further driving the advancement of research in the pharmaceutical industry.

Conclusion

Christopher Don Roberts exemplifies the spirit of innovation through his work on antibacterial and antifungal agents. By focusing on the development of novel pharmaceutical compounds, he is playing a crucial role in enhancing healthcare solutions. His contributions to Genelabs Technologies, Inc. and the broader scientific community highlight the importance of continued research and collaboration in fostering breakthroughs in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…